OncoLink at ASCO 2001: Saturday, May 12

OncoLink Booth at ASCO
Managing Editor, Maggie Hampshire, RN, BSN, OCN helps conference goers fill-out the OncoLink/Elsevier Survey.

A Prospective Randomized Trial of Prophylactic Platelet Transfusion and Bleeding Incidence in Hematopoietic Stem Cell Transplant (HSCT) Recipients: 10, 000 μL vs. 20,000 μL Threshold A Randomized, Double-blind, Phase III Study Evaluating Fixed Dose, Once-Per-Cycle Pegylated Filgrastim (SD/01) vs Daily Filgrastim to Support Chemotherapy for Breast Cancer A single Dose of Pegylated Filgrastim (SD/01) is as effective as Daily Filgrastim for Hematologic Support of Chemotherapy in Breast Cancer Patients: Results of a Randomized,k Double-Blind, Phase 3 Trial Amifostine (AF) Cytoprotetion (CP) of Escalating Doses of Melphalan (MEL) and Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Final Results of a Phase I & II study An EORTC Randomized Phase III Trial of Three Chemotherapy Regimens in Advanced Non-Small Cell Lung Cancer (NSCLC) ASCO/European Society for Medical Oncology Joint Session Addresses the Clinical and Ethical Implications of the Human Genome Project Cisplatin/Gemcytobine (CG) vs Cisplatin/Gemcytobine/Vinorelbine (CGV) vs Sequential Doublets of Gemcytobine/Vinorelbine Followed by Ifosfamide/Vinorelbine (GV/IV) in Advanced Non-Small Cell Lung Cancer (NSCLC): Results of a Spanish Lung Cancer Group Phase Efficacy of Recombinant Human Keratinocyte Growth Factor (rHuKGF) in Reducing Mucositis in Patients with Hematologic Malignancies Undergoing Autologous Peripheral Blood Progenitor Cell Transplantation (auto-PBPCT) After Radiation-Based Conditioning ? Resu Health outcomes following primary Androgen therapy in a population-based cohort How Much Chemotherapy Are Cancer Patients Receiving at the End of Life? Informed consent to cancer clinical trials Keeping cancer guidelines current: results of a comprehensive prospective literature monitoring strategy Myelodysplastic (MDS) Syndrome and Leukemia After Autotransplantation for Lymphoma: a Multicenter Case-Control Study Non-Adherence with Adjuvant Tamoxifen Therapy in Women with Early Stage Breast Cancer Opening Address: NCI Director Dr. Richard Klausner Welcomes ASCO Members Providing Audiotapes of Primary Adjuvant Treatment Consultations to Women with Breast Cancer: a Multi-Site Randomized Controlled Trial Results of a Spanish Lung Cancer Group Phase III Trial Satisfaction and anxiety are improved with the use of an easy-to-read informed consent document: a randomized multi-group study The Effect of Hospital Volume and Socioeconomic Status on Colostomy Rates for Rectal Cancer The Quality of Non-Cancer Care Delivered to Elderly Breast Cancer Survivors


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

The number increased from 9.8 million in 2001 to almost 12 million in 2007

Mar 11, 2011

The number increased from 9.8 million in 2001 to almost 12 million in 2007

ASCO: Rx Strategies Promising for CLL, Non-Hodgkin's Lymphoma

Jun 2, 2015

Ibrutinib, obinutuzumab slow progression of CLL, non-Hodgkin's lymphoma

ASCO: Lymph Node Sx Doesn't Benefit All Melanoma Patients

Jun 2, 2015

Second study supports new immunotherapy for enhanced survival in advanced melanoma